{
  "source": "Insider Whispers",
  "source_name": "Insider Whispers",
  "meta_source_name": "Insider Whispers",
  "source_guid": "src-rumor-mill",
  "trust_level": 2,
  "source_type": "NEWS_WIRE",
  "group_guid": "group-simulation",
  "event_type": "PRODUCT_RECALL",
  "published_at": "2025-12-27T14:10:34.606759",
  "upload_as_group": "group-simulation",
  "token": "eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJqdGkiOiI5ZGEyZjk3Ni04YjRmLTRlNzQtOGNlOS03YjNkOWNhYjRlZDAiLCJncm91cHMiOlsiYWRtaW4iXSwiaWF0IjoxNzY5NzI2NjQ0LCJleHAiOjIwODUwODY2NDQsIm5iZiI6MTc2OTcyNjY0NCwiYXVkIjoiZ29mci1hcGkifQ.1DY75mere_IuvVYVOOSfCGqO1spzzFaDT_sjfHJZLf8",
  "title": "Update regarding OmniCorp",
  "story_body": "BOMBSHELL IN PHARMA SECTOR: VITALITY PHARMA ROCKED BY PRODUCT RECALL\n\nIn a stunning turn of events, Vitality Pharma (VIT) has issued a RECALL of its FLAGSHIP PRODUCT, citing \"quality control issues\". Sources close to the company describe the situation as a \"FULL-BLOWN CRISIS\", with insiders whispering about a \"TOXIC\" corporate culture that may have contributed to the debacle.\n\nUnconfirmed reports suggest that the recall is just the TIP OF THE ICEBERG, with rumors swirling about a potential CLASS-ACTION LAWSUIT and regulatory investigations looming on the horizon. The company's reputation is in TATTERS, with investors bracing for a potentially CATASTROPHIC impact on the stock price.\n\nMeanwhile, rival pharma giant OmniCorp (OMNI) is watching the drama unfold with GREAT INTEREST. As a DIRECT COMPETITOR, OmniCorp stands to GAIN SIGNIFICANT MARKET SHARE in the wake of Vitality Pharma's misfortune. Insiders claim that OmniCorp has been secretly courting Vitality Pharma as a potential acquisition target, and this latest development may have just TIPPED THE SCALES in their favor.\n\nWhile Vitality Pharma struggles to contain the fallout, OmniCorp is poised to CAPITALIZE ON THE CHAOS. Sources say that OmniCorp's top brass is \"SALIVATING\" at the prospect of swooping in and snagging Vitality Pharma's prized assets at a FIRE-SALE PRICE.\n\nAs the situation continues to UNFOLD, one thing is clear: Vitality Pharma's product recall has opened the door for OmniCorp to make a POWER PLAY. Will Vitality Pharma be able to recover from this devastating blow, or will OmniCorp ultimately emerge as the BIG WINNER? Only time will tell.",
  "validation_metadata": {
    "scenario": "Competitor Product Recall",
    "base_ticker": "OMNI",
    "expected_tier": "SILVER",
    "expected_event": "PRODUCT_RECALL",
    "expected_relevant_clients": [
      "550e8400-e29b-41d4-a716-446655440002",
      "550e8400-e29b-41d4-a716-446655440001"
    ],
    "relationship_hops": 2,
    "expected_feed_rank_range": "6-15",
    "validation_rules": {
      "min_score": 50,
      "max_score": 74,
      "expected_tier": "SILVER",
      "must_match_event": false,
      "expected_event": "PRODUCT_RECALL",
      "expected_entities": [],
      "expected_relevant_clients": [],
      "relationship_hops": 2,
      "expected_feed_rank_range": "6-15"
    }
  }
}